Skip to Main Content
Pharmacist's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Interactions
  4. Women's Health
  5. Raloxifene

Raloxifene

  • Bone & Joint (68)
  • Cardiology (285)
  • Dermatology (53)
  • Diabetes & Endocrinology (44)
  • Gastroenterology (85)
  • Hematology & Oncology (6)
  • Infectious Diseases (238)
  • Men's Health (3)
  • Natural Medicines / Supplements / Food Interactions (147)
  • Neurology (126)
  • Nutrition & Obesity (9)
  • Psychiatry (146)
  • Resources (41)
  • Respiratory & Allergy (15)
  • Transplant Meds (14)
  • Women's Health (52)
    • Oral Contraceptives (46)
    • Raloxifene (7)
1 - 7 of 7 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
FAQ: Meds to Prevent Breast Cancer: FAQs November 2019
Chart: Comparison of Angiotensin Receptor Blockers (ARBs) September 2018
Article: Watch for Some Risky Drug-Supplement Combinations May 2016
PL Voices: Drug Therapy for Primary Prevention of Breast Cancer September 2013
Commentary: Olmesartan and Severe Intestinal Problems September 2013
Other: Breast Cancer Risk Calculator September 2013
Article: a stronger push to offer drug therapy for primary prevention of breast cancer in higher-risk women September 2013
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved